• 6 years of Clinical Research, Characterized 3,400 colorectal cancer and 3,700 breast cancer patients and 1st degree relative germline DNA for cancer risk association. • Genotyped GC-rich DNA regions, identifying specific mutations with focus on high-throughput process improvement (GLP). Identified 3 novel biomarkers.• Delivered results in Western blotting, PCR, q-PCR, in vitro cell assays (tumor and non-tumor cells), ELISA, and in vivo studies with transgenic murine models. • Acted as a bridge and delivered results between clinicians, data scientists, and research scientists, in data collection and analysis.• Managed multiple different projects, 10+ public seminar presentations and highly-collaborative across different departments.